#IDIBELLfellows: Virginia Díez-Obrero / Léa Pourchet
Virginia Díez-Obrero
Léa Pourchet
Colorectal Cancer Group
Stem Cell Potency Group
Microsoft Teams
#IDIBELLconnect: Dissecting mechanisms of therapy resistance in lethal prostate cancer
Alvaro Aytés
Resistance and Progression Mechanisms in Prostate Cancer Group, IDIBELL
Microsoft Teams
#IDIBELLfellows: Carmen Martínez-Fernández / Mercè Cases Escuté
Carmen Martínez-Fernández
Mercè Cases Escuté
Modeling Human Diseases in C. elegans Group
Cellular and Molecular Neurobiology Group
Microsoft Teams
Joint webinar #IDIBELLseminars #IDIBELLequality: Social and mental health impact on women in times of COVID-19
Zulema Altamirano
Susana Jiménez
Senior Officer at the Cabinet of the Minister of Science & Innovation – Director of the Women & Science Unit, Spain
Psychiatry and Mental Health research group, and head of the Pathological Gambling Unit, HUB
Microsoft teams
#IDIBELLconnect: Modeling cellular plasticity to regenerate the intestine
Jordi Guiu
Bellvitge Biomedical Research Institute (IDIBELL), Spain
Program for Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C])
Microsoft Teams Meeting
Webinar IRISCAT-Dr. Rafael Máñez «Generació d’immunitat protectora contra les infeccions»
Rafael Máñez Mendiluce
Cap del Servei de Medicina Intensiva. Hospital Universitari de Bellvitge.
Online
#IDIBELLconnect: The TGF-β pathway: A pharmacological target in hepatocellular carcinoma?
Isabel Fabregat
Bellvitge Biomedical Research Institute (IDIBELL), Spain
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Spain
University of Barcelona (UB), Spain
Microsoft Teams Meeting
#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
Microsoft Teams Meeting
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
Microsoft Teams Meeting
Charlas Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
Online y en directo:
https://sinergia.l-h.cat/
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
Founder and President of the IDIBELL spin-off RemAb Therapeutics
Microsoft Teams Meeting
PhD Day 2020
12-13 November 2020
this event is being held online
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
Microsoft Teams meeting
VII Programa de excelencia en el abordaje del paciente con EM de alta actividadVII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h